Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer...

by Au, H., Eiermann, W., Robert, N., Pienkowski, T., Crown, J., Martin, M., Pawlicki, M., Chan, Arlene, Mackey, J., Glaspy, J., Pintér, T., Liu, M., Fornander, T., Sehdev, S., Ferrero, J., Bée, V., Santana, M., Miller, D., Lalla, D., Slamon, D.
Published 2013

Adjuvant trastuzumab in HER2-positive breast cancer.

by Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, Arlene, Pawlicki, M., Pinter, T., Valero, V., Liu, M., Sauter, G., von Minckwitz, G., Visco, F., Bee, V., Buyse, M., Bendahmane, B., Tabah-Fisch, I., Lindsay, M., Riva, A., Crown, J., Breast, C.
Published 2011